FDA+ channel feed – Endpoints News

FDA+ channel feed

That bullish stance Karyopharm took on its subgroup cancer study data? The FDA wasn't impressed

4 years ago

FDA quickly follows a voluntary pause for CAR-T 2.0 with a clinical hold to investigate 2 patient deaths

4 years ago

SEC jumps into the FibroGen fiasco with a subpoena, probing cardio data manipulation

4 years ago

Improving cancer drug research: FDA reworks and finalizes guidance documents

4 years ago

A new JAK inhibitor earns FDA nod in myelofibrosis, setting up a fight with Incyte, Bristol Myers

4 years ago

FDA rejects Gilead’s next big HIV drug over glass vial issues

4 years ago

Deserted by Sanofi, Lexicon discloses last-minute hiccup in its solo fight to get sotagliflozin approved

4 years ago

'We are ready to go': FDA OKs J&J and Legend's BCMA CAR-T, setting stage for showdown with Bristol Myers

4 years ago

Hold the phone, biopharma: FDA-imposed clinical holds are on the rise

4 years ago

After being ushered onto the inside lane at FDA, regulators hand Amryt a CRL for rare disease drug

4 years ago

FDA rejects Reata's kidney drug after adcomm voted unanimously against it

4 years ago

More than 100 House and Senate Republicans call on new FDA commish to reverse order on mail-order abortion pills

4 years ago

Watch out, Novartis: Eli Lilly, Boehringer Ingelheim notch broad heart failure OK for Jardiance

4 years ago

AstraZeneca's Evusheld and GSK's sotrovimab lose efficacy against Omicron's subvariants

4 years ago

Orphazyme runs into another setback as Europe appears unlikely to approve its FDA-rejected drug

4 years ago

Public Citizen picks apart Cures 2.0 draft legislation, criticizing several RWE provisions

4 years ago

When a citizen petition works: FDA's review of United Therapeutics' PAH drug extended to May

4 years ago

Canada wants to clear the way for more decentralized clinical trials: Will the US follow suit?

4 years ago

FDA+ roundup: Assessor finds FDA's new biosimilar review model makes the process more predictable

4 years ago

Almost 9 in 10 Americans want the FDA to explain why some drugs are rejected, new JAMA survey finds

4 years ago

FDA slams former CytoDyn CEO's misleading interview in new warning letter

4 years ago

Tiny pharma hits a new low with FDA refusing to review company's response to its CRL

4 years ago

FDA updates Merck's Covid-19 pill EUA and reaffirms it should only be used as a last resort

4 years ago

FDA starts probe into a clinical trial death as next-gen CAR-T researchers stop enrollment

4 years ago

First page Previous page 87 88 899091 92 93 Next page Last page